France· FR:65689785
NUVAXOVID XBB.1.5, dispersion injectable. Vaccin contre la COVID-19 (recombinant, avec adjuvant)
A medicinal product containing protéine spike (s) recombinante du sars-cov-2, variant omicron xbb.1.5, registered in France by SANOFI WINTHROP INDUSTRIE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PROTÉINE SPIKE (S) RECOMBINANTE DU SARS-COV-2, VARIANT OMICRON XBB.1.5
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302774092 flacons multidoses en verre de 2,5 mL de 5 doses (10 doses)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdf6026a-730e-4389-b8ec-37f8abc15ad3 GET /v1/drugs/bdf6026a-730e-4389-b8ec-37f8abc15ad3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65689785",
"date_amm": "2023-10-31",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1618",
"substance": "PROTÉINE SPIKE (S) RECOMBINANTE DU SARS-COV-2, VARIANT OMICRON XBB.1.5",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "dispersion injectable",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Oui"
}See everything about protéine spike (s) recombinante du sars-cov-2, variant omicron xbb.1.5.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.